BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Y, Mei X, Gan D, Wu Z, Cao Y, Lin M, Zhang N, Yang T, Chen Y, Hu J. Integration of bioinformatics and experiments to identify TP53 as a potential target in Emodin inhibiting diffuse large B cell lymphoma. Biomed Pharmacother 2018;107:226-33. [PMID: 30096626 DOI: 10.1016/j.biopha.2018.07.168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Q, Li S, Li X, Liu R. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis. Chin Med 2021;16:102. [PMID: 34629100 DOI: 10.1186/s13020-021-00509-z] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
2 Zheng J, Chen Y, Zheng Z, Chen Y, Chai Y, Wang W, Asakawa T, Hu J. In Vitro Investigation of the Cytotoxic Activity of Emodin 35 Derivative on Multiple Myeloma Cell Lines. Evid Based Complement Alternat Med 2021;2021:6682787. [PMID: 33564319 DOI: 10.1155/2021/6682787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li D, Lv B, Wang D, Xu D, Qin S, Zhang Y, Chen J, Zhang W, Zhang Z, Xu F. Network Pharmacology and Bioactive Equivalence Assessment Integrated Strategy Driven Q-markers Discovery for Da-Cheng-Qi Decoction to Attenuate Intestinal Obstruction. Phytomedicine 2020;72:153236. [DOI: 10.1016/j.phymed.2020.153236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen Y, Zheng J, Gan D, Chen Y, Zhang N, Chen Y, Lin Z, Wang W, Chen H, Lin D, Hu J. E35 ablates acute leukemia stem and progenitor cells in vitro and in vivo. J Cell Physiol 2020;235:8023-34. [PMID: 31960417 DOI: 10.1002/jcp.29457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]